Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
John J. P. Kastelein
Based on 37 articles published since 2008
||||
Expertise Level
The expertise of John J. P. Kastelein ranks in the
  • Top 0.039%
  • ... of 27,988 published authors worldwide on Hypercholesterolemia
  • ... from 2008 through 2018
  • ... based on contributions to 37 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Kastelein, J J   ·   Kastelein, John J P   ·   Kastelein, John J   ·   Kastelein, J J P
Work Locations
Details
Most likely:    University of Amsterdam      
2017
  • Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Robertson Centre for Biostatistics, University of Glasgow, United Kingdom (M.R., I.F.). · Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano and IRCCS Multimedica, Italy (A.L.C.). · Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia (G.F.W.). · Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (J.J.K.). · College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (C.J.P.). · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Pubmed 28877913
  • Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, Michigan. · Institute for Advanced Studies, University of Bristol, Bristol, United Kingdom. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Irving Institute for Clinical and Translational Research, Columbia University College of Physicians and Surgeons, New York, New York. · National Institute for Health and Medical Research (INSERM), Pitie-Salpetriere University Hospital, Paris, France. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Department of Cardiology, University of Leipzig, Leipzig, Germany. · Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor. · MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, United Kingdom. · Wellcome Trust Sanger Institute, Hinxton, United Kingdom. · MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. · Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCCS, Milano, Italy. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28846118
  • University of Iowa, Iowa City, Iowa. Electronic address: · Icahn School of Medicine at Mount Sinai, New York, New York. · Point Médical, Dijon, France. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28153102
2016
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: · Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Department of Paediatrics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 27578116
  • Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Paris-Diderot, Sorbonne University, Paris, France. · Pfizer Inc, New York, NY. · Leiden University Medical Center, Leiden, the Netherlands. · Academic Medical Center of the University of Amsterdam, Amsterdam, Netherlands. · Deutsches Herzzentrum München, Technische Universität München, Munich, Germany. · Cleveland Clinic Foundation, Cleveland, OH. · Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil. · Montreal Heart Institute, Université de Montréal, Montreal, Canada. · Pubmed 27502861
2015
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, PO Box 22660, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, PO Box 22660, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, PO Box 22660, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. · Pubmed 26456772
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: · Merck and Co, Inc, Whitehouse Station, NJ. · Centro Almirante Colon, Bogota, Colombia. · La Clinique des Maladies Lipidiques de Quebec, Inc, Quebec, Quebec, Canada. · ProHealth Care Associates, New York, NY. · The Johns Hopkins University, Baltimore, MD. · MSD Belgium, Brussels, Belgium. · The Hospital for Sick Children, Toronto, Ontario, Canada. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 25841542
2014
  • The Sterling Research Group, Cincinnati, OH, USA. Electronic address: · Cardiovascular Research Unit, Diabetes and Obesity Research Program, University of Helsinki, Finland. · Columbia University, New York, NY, USA. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Medical Research Institute, University of Dundee, Dundee, UK. · College of Public Health, University of Iowa, IA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Montpellier, France. · Pubmed 25037695
2017
  • From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.), and Knowle House Surgery, Plymouth (T.H.) - both in the United Kingdom; the Department of Cardiology, Charité-Universitätsmedizin Berlin, Berlin Institute of Health and German Center for Cardiovascular Research, Berlin (U.L.), and University Heart Center Hamburg, Department of General and Interventional Cardiology, Hamburg (M.K.) - all in Germany; the Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.); the Medicines Company, Parsippany, NJ (D.K., P.W.); Institut de Recherches Cliniques de Montréal, University of Montreal, Montreal (R.D.); the Department of Cardiology and Interventional Cardiology, VieCuri Medical Center for Northern Limburg, Venlo (R.P.T.T.), University Medical Center, Utrecht (F.L.J.V.), and the Department of Vascular Medicine, Academic Medical Center-University of Amsterdam, Amsterdam (J.J.P.K.) - all in the Netherlands; the Metabolic and Atherosclerosis Research Center, Medpace, Cincinnati (T.T.); and the Department of Cardiology, Mayo Clinic, Rochester, MN (R.S.W.). · Pubmed 28306389
  • From Brigham and Women's Hospital and Harvard Medical School, Boston (P.M.R., R.J.G.); Pfizer, New York (J.R., R.B., M.C., U.M., P.F.S., C.Y., C.L.S.); Paris-Diderot, Sorbonne Paris Cité University, Paris (P.A.); Universidad de Zaragoza, IIS Aragon, Zaragoza, Spain (F.C.); University of East Anglia, Norwich (M.F.), and Central Manchester University Hospital, Manchester (H.S.) - both in the United Kingdom; the Montreal Heart Institute, Université de Montréal, Montreal (J.G., J.-C.T.); Leiden University Medical Center, Leiden (J.W.J.), Academic Medical Center of the University of Amsterdam, Amsterdam (J.J.P.K.), and Meander Medical Center, Amersfoort (A.M.) - all in the Netherlands; Russian Cardiology Research and Production Center, Moscow (Y.K.); Deutsches Herzzentrum München, Technische Universität München, Munich Heart Alliance, Munich, Germany (W.K.); Cordoba Hospital, Cordoba, Argentina (A.L.); University of the Witwatersrand, Johannesburg (P.M.); University of Maryland, Baltimore (M.M.); University of Comenius, Bratislava, Slovakia (J.M.); Heart Institute, University of São Paulo Medical School (J.C.N.), and Lipid Clinic Heart Institute, University of São Paulo Medical School Hospital (R.D.S.), São Paulo; Cleveland Clinic Foundation, Cleveland (S.N.); Wroclaw Medical University, Wroclaw, Poland (P.P.); Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand (H.W.); Mayo Clinic, Rochester, MN (R.S.W.); and First Faculty of Medicine, Charles University, Prague, Czech Republic (M.V.). · Pubmed 28304242
  • From Brigham and Women's Hospital, Harvard Medical School, Boston (P.M.R., R.J.G., L.M.R.); Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.); Pierre et Marie Curie University, Paris (P.A.); Pfizer, New York (W.D., A.M.K., J.R., P.F.S., C.L.S., C.Y.); Leiden University Medical Center, Leiden (J.W.J.), and Academic Medical Center of the University of Amsterdam, Amsterdam (J.J.P.K.) - both in the Netherlands; Deutsches Herzzentrum München, Technische Universität München, DZHK (German Center for Cardiovascular Research), Munich Heart Alliance, Munich, Germany (W.K.); Cleveland Clinic Foundation, Cleveland (S.N.); and the Lipid Clinic Heart Institute, University of São Paulo Medical School Hospital, São Paulo (R.D.S.). · Pubmed 28304227
2014
  • Academic Medical Center, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands, · Pubmed 24385386
2013
  • Department of Vascular Medicine, Academic Medical Centre, Meibergdreef 15, Room F4-139, 1105 AZ, Amsterdam, The Netherlands. · Pubmed 23494186
  • From the Cardiovascular Division, Department of Medicine (N.O.S.) and Division of Statistical Genomics (N.O.S.), Washington University School of Medicine, Saint Louis, MO; Department of Vascular Medicine (B.S., S.S., J.J.P.K., G.K.H.) Department of Experimental Vascular Medicine (S.W.F., J.C.D), and Radiology (A.J.N.), Academic Medical Center, Amsterdam, The Netherlands; Center for Human Genetic Research, Boston, MA (G.M.P., A.M.M., D.A., S.K.); Program in Medical and Population Genetics, Broad Institute, Cambridge, MA (G.M.P., A.M.M., D.A., S.K.); Fred Hutchinson Cancer Research Center, Seattle, WA (P.L.A., C.K.); Wellcome Trust Centre for Human Genetics (A.G., M.F., H.W.) and Cardiovascular Medicine, Radcliffe Department of Medicine (A.G., M.F., H.W.), University of Oxford, Oxford, United Kingdom; Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (B.G., U.d.F.); Department of Cardiovascular Sciences, University of Leicester and Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital, Leicester, United Kingdom (T.A.B., N.J.S.); Department of Clinical Sciences, Hypertension and Cardiovascular Diseases (O.M.) and Diabetes and Cardiovascular Disease Genetic Epidemiology (M.O.-M.), Skania University Hospital, Lund University, Malmö, Sweden; Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy (S.D.); Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (M.N.); Department of Medicine, University of Verona, Verona, Italy (N.M., D.G.); Division of Endocrinology, Diabetes and Metabolism, Ohio State University, Columbus (R.D.J.); Departments of Epidemiology, Genetics and Biostatistics, Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill (L.A.L.); Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy (D.A.); The John & Jennif · Pubmed 24072694
2012
  • Department of Vascular Medicine of the Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22390808
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22507979
  • Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22453571
  • Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22284919
2011
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 21938413
  • Department of Vascular Medicine, Academic Medical Center Amsterdam, Meibergdreef 9, PO Box 22660, 1100 DD, Amsterdam, The Netherlands. · Pubmed 21593041
2010
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 20581104
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 20378080
  • Department of Vascular Medicine, Academic Medical Centre, F4-159.2, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 20655044
2009
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. · Pubmed 19741526
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 19895941
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 18695266
2008
  • Department of Vascular Medicine, Room F4-159.2, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 18950563
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 37 total) written by John J. P. Kastelein about Hypercholesterolemia:

  • Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol. 2017
  • Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up. 2017
  • Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. 2017
  • Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. 2017
  • Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. 2017
  • Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials. 2017
  • Children with hypercholesterolemia of unknown cause: Value of genetic risk scores. 2016
  • Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials. 2016
  • PCSK9 inhibition: the way forward in the treatment of dyslipidemia. 2015
  • Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia. 2015
Show List of Full Article Records
Google Searches

Learn more about John J. P. Kastelein using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Amsterdam
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Amsterdam
2017
  • Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Robertson Centre for Biostatistics, University of Glasgow, United Kingdom (M.R., I.F.). · Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano and IRCCS Multimedica, Italy (A.L.C.). · Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia (G.F.W.). · Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (J.J.K.). · College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (C.J.P.). · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.). · Pubmed 28877913
  • Division of Cardiovascular Medicine, Wayne State University School of Medicine, Detroit, Michigan. · Institute for Advanced Studies, University of Bristol, Bristol, United Kingdom. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Irving Institute for Clinical and Translational Research, Columbia University College of Physicians and Surgeons, New York, New York. · National Institute for Health and Medical Research (INSERM), Pitie-Salpetriere University Hospital, Paris, France. · South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. · Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Department of Cardiology, University of Leipzig, Leipzig, Germany. · Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor. · MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, United Kingdom. · Wellcome Trust Sanger Institute, Hinxton, United Kingdom. · MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. · Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCCS, Milano, Italy. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28846118
  • University of Iowa, Iowa City, Iowa. Electronic address: · Icahn School of Medicine at Mount Sinai, New York, New York. · Point Médical, Dijon, France. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28153102
2016
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: · Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Department of Paediatrics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 27578116
  • Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Paris-Diderot, Sorbonne University, Paris, France. · Pfizer Inc, New York, NY. · Leiden University Medical Center, Leiden, the Netherlands. · Academic Medical Center of the University of Amsterdam, Amsterdam, Netherlands. · Deutsches Herzzentrum München, Technische Universität München, Munich, Germany. · Cleveland Clinic Foundation, Cleveland, OH. · Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil. · Montreal Heart Institute, Université de Montréal, Montreal, Canada. · Pubmed 27502861
2015
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, PO Box 22660, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, PO Box 22660, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, PO Box 22660, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. · Pubmed 26456772
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: · Merck and Co, Inc, Whitehouse Station, NJ. · Centro Almirante Colon, Bogota, Colombia. · La Clinique des Maladies Lipidiques de Quebec, Inc, Quebec, Quebec, Canada. · ProHealth Care Associates, New York, NY. · The Johns Hopkins University, Baltimore, MD. · MSD Belgium, Brussels, Belgium. · The Hospital for Sick Children, Toronto, Ontario, Canada. · Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 25841542
2014
  • The Sterling Research Group, Cincinnati, OH, USA. Electronic address: · Cardiovascular Research Unit, Diabetes and Obesity Research Program, University of Helsinki, Finland. · Columbia University, New York, NY, USA. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Medical Research Institute, University of Dundee, Dundee, UK. · College of Public Health, University of Iowa, IA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Montpellier, France. · Pubmed 25037695
2017
  • From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.), and Knowle House Surgery, Plymouth (T.H.) - both in the United Kingdom; the Department of Cardiology, Charité-Universitätsmedizin Berlin, Berlin Institute of Health and German Center for Cardiovascular Research, Berlin (U.L.), and University Heart Center Hamburg, Department of General and Interventional Cardiology, Hamburg (M.K.) - all in Germany; the Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.); the Medicines Company, Parsippany, NJ (D.K., P.W.); Institut de Recherches Cliniques de Montréal, University of Montreal, Montreal (R.D.); the Department of Cardiology and Interventional Cardiology, VieCuri Medical Center for Northern Limburg, Venlo (R.P.T.T.), University Medical Center, Utrecht (F.L.J.V.), and the Department of Vascular Medicine, Academic Medical Center-University of Amsterdam, Amsterdam (J.J.P.K.) - all in the Netherlands; the Metabolic and Atherosclerosis Research Center, Medpace, Cincinnati (T.T.); and the Department of Cardiology, Mayo Clinic, Rochester, MN (R.S.W.). · Pubmed 28306389
  • From Brigham and Women's Hospital and Harvard Medical School, Boston (P.M.R., R.J.G.); Pfizer, New York (J.R., R.B., M.C., U.M., P.F.S., C.Y., C.L.S.); Paris-Diderot, Sorbonne Paris Cité University, Paris (P.A.); Universidad de Zaragoza, IIS Aragon, Zaragoza, Spain (F.C.); University of East Anglia, Norwich (M.F.), and Central Manchester University Hospital, Manchester (H.S.) - both in the United Kingdom; the Montreal Heart Institute, Université de Montréal, Montreal (J.G., J.-C.T.); Leiden University Medical Center, Leiden (J.W.J.), Academic Medical Center of the University of Amsterdam, Amsterdam (J.J.P.K.), and Meander Medical Center, Amersfoort (A.M.) - all in the Netherlands; Russian Cardiology Research and Production Center, Moscow (Y.K.); Deutsches Herzzentrum München, Technische Universität München, Munich Heart Alliance, Munich, Germany (W.K.); Cordoba Hospital, Cordoba, Argentina (A.L.); University of the Witwatersrand, Johannesburg (P.M.); University of Maryland, Baltimore (M.M.); University of Comenius, Bratislava, Slovakia (J.M.); Heart Institute, University of São Paulo Medical School (J.C.N.), and Lipid Clinic Heart Institute, University of São Paulo Medical School Hospital (R.D.S.), São Paulo; Cleveland Clinic Foundation, Cleveland (S.N.); Wroclaw Medical University, Wroclaw, Poland (P.P.); Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand (H.W.); Mayo Clinic, Rochester, MN (R.S.W.); and First Faculty of Medicine, Charles University, Prague, Czech Republic (M.V.). · Pubmed 28304242
  • From Brigham and Women's Hospital, Harvard Medical School, Boston (P.M.R., R.J.G., L.M.R.); Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.); Pierre et Marie Curie University, Paris (P.A.); Pfizer, New York (W.D., A.M.K., J.R., P.F.S., C.L.S., C.Y.); Leiden University Medical Center, Leiden (J.W.J.), and Academic Medical Center of the University of Amsterdam, Amsterdam (J.J.P.K.) - both in the Netherlands; Deutsches Herzzentrum München, Technische Universität München, DZHK (German Center for Cardiovascular Research), Munich Heart Alliance, Munich, Germany (W.K.); Cleveland Clinic Foundation, Cleveland (S.N.); and the Lipid Clinic Heart Institute, University of São Paulo Medical School Hospital, São Paulo (R.D.S.). · Pubmed 28304227
2014
  • Academic Medical Center, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands, · Pubmed 24385386
2013
  • Department of Vascular Medicine, Academic Medical Centre, Meibergdreef 15, Room F4-139, 1105 AZ, Amsterdam, The Netherlands. · Pubmed 23494186
  • From the Cardiovascular Division, Department of Medicine (N.O.S.) and Division of Statistical Genomics (N.O.S.), Washington University School of Medicine, Saint Louis, MO; Department of Vascular Medicine (B.S., S.S., J.J.P.K., G.K.H.) Department of Experimental Vascular Medicine (S.W.F., J.C.D), and Radiology (A.J.N.), Academic Medical Center, Amsterdam, The Netherlands; Center for Human Genetic Research, Boston, MA (G.M.P., A.M.M., D.A., S.K.); Program in Medical and Population Genetics, Broad Institute, Cambridge, MA (G.M.P., A.M.M., D.A., S.K.); Fred Hutchinson Cancer Research Center, Seattle, WA (P.L.A., C.K.); Wellcome Trust Centre for Human Genetics (A.G., M.F., H.W.) and Cardiovascular Medicine, Radcliffe Department of Medicine (A.G., M.F., H.W.), University of Oxford, Oxford, United Kingdom; Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (B.G., U.d.F.); Department of Cardiovascular Sciences, University of Leicester and Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital, Leicester, United Kingdom (T.A.B., N.J.S.); Department of Clinical Sciences, Hypertension and Cardiovascular Diseases (O.M.) and Diabetes and Cardiovascular Disease Genetic Epidemiology (M.O.-M.), Skania University Hospital, Lund University, Malmö, Sweden; Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy (S.D.); Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (M.N.); Department of Medicine, University of Verona, Verona, Italy (N.M., D.G.); Division of Endocrinology, Diabetes and Metabolism, Ohio State University, Columbus (R.D.J.); Departments of Epidemiology, Genetics and Biostatistics, Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill (L.A.L.); Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy (D.A.); The John & Jennif · Pubmed 24072694
2012
  • Department of Vascular Medicine of the Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22390808
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22507979
  • Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22453571
  • Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22284919
2011
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 21938413
  • Department of Vascular Medicine, Academic Medical Center Amsterdam, Meibergdreef 9, PO Box 22660, 1100 DD, Amsterdam, The Netherlands. · Pubmed 21593041
2010
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 20581104
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 20378080
  • Department of Vascular Medicine, Academic Medical Centre, F4-159.2, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 20655044
2009
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. · Pubmed 19741526
  • Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Pubmed 19895941
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 18695266
2008
  • Department of Vascular Medicine, Room F4-159.2, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 18950563
54 Other Locations Show
Yearly article counts 06243273433
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.